Stem Cells Europe
Recommend Cell Cycle to your librarian for 2008. Download form here.

Sign up for Table of Contents Alerts.

home subscribe search archive forthcoming

Email this page Print this page

Extra Views

Beyond focal adhesions: Integrin linked kinase associates with tubulin and regulates mitotic spindle organization

Andrew B. Fielding, Iveta Dobreva and Shoukat Dedhar

volume 7 | issue 13

1 July 2008

Purchase article for $19

Subscribe to this journal for $129/year

Integrin Linked kinase (ILK) is a member of a multiprotein complex at focal adhesions which interacts with actin. Here, it functions as a kinase and adapter protein to regulate diverse cellular processes. Gene knockout studies have demonstrated critical roles for ILK in embryonic development and in organ and tissue homeostasis. However, ILK is overexpressed in many human cancers and experimental overexpression in non-transformed cells results in the acquisition of several oncogenic phenotypes. Proteomic based approaches to identify ILK binding partners have now identified tubulins and many centrosomal and mitotic spindle associated proteins as ILK interactors in addition to the expected focal adhesion, actin interacting, proteins. Further analysis has shown that ILK co-localizes with several of these proteins to the centrosome and inhibition or depletion of ILK causes mitotic spindle defects by disrupting Aurora A kinase/TACC3/ch-TOG interactions. Here we discuss the finding that ILK is a member of a tubulin-based multiprotein complex at the centrosome, whether this may interact with the focal adhesion pool of ILK, and identify potential mechanisms by which ILK regulates the organization of the mitotic spindle. We also discuss the implications of ILK’s mitotic role for cancer progression and highlight the potential use of ILK inhibitors as novel anti-mitotic chemotherapeutics.

Authors

Andrew B. Fielding

British Columbia Cancer Research Centre of the BC Cancer Agency

Iveta Dobreva

University of British Columbia

Shoukat Dedhar

British Columbia Cancer Research Centre of the BC Cancer Agency


Purchase article for $19

Subscribe to this journal for $129/year